Summary 2: Progress Depends on Collaboration and Cooperation
Pediatric cancer researchers (clinical and laboratory) and health care professionals
Families and their advocates
National Cancer Institute
Academic and pharmaceutical developers of new cancer treatments and the FDA
Working together so that the most promising therapeutic approaches are expeditiously evaluated with the ultimate objective of improving outcome for children with cancer